SETD2 and neoplasm: Thus, given its frequency of inactivation in ccRCC, its critical role as a tumor suppressor, and its possible use as progression marker in ccRCC, effort have been placed to elucidate the biological consequences of SETD2 loss of function in ccRCC cells.